XTX Topco’s Olema Pharmaceuticals OLMA Stock Holding History

XTX Topco’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.12M	Sell	89,525 -33,693	-27%	-$451K	0.01%	1686
2026 Q1	$1.84M	Buy	+123,218	New	+$2.74M	0.03%	901
2025 Q3	–	Sell	-80,414	Closed	-$343K	–	3061
2025 Q2	$343K	Buy	+80,414	New	+$359K	0.01%	1339
2025 Q1	–	Sell	-48,032	Closed	-$280K	–	2898
2024 Q4	$280K	Buy	48,032 +22,700	+90%	+$227K	0.02%	1287
2024 Q3	$302K	Buy	25,332 +12,878	+103%	+$165K	0.02%	1178
2024 Q2	$135K	Sell	12,454 -14,505	-54%	-$157K	0.01%	1347
2024 Q1	$305K	Buy	+26,959	New	+$348K	0.04%	839
2022 Q3	–	Sell	-16,607	Closed	-$68K	–	1305
2022 Q2	$68K	Buy	+16,607	New	+$52.7K	0.03%	717

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

XTX Topco's OLMA Position: Q2 2026 in Review

XTX Topco reduced its Olema Pharmaceuticals (OLMA) stake by 27% in Q2 2026, selling an estimated $451K and leaving 89,525 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #1686.

XTX Topco first reported a position in OLMA in Q2 2022 and has held it in 8 quarters since. The position peaked at $1.84M in Q1 2026. 184 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

XTX Topco held 89,525 shares of Olema Pharmaceuticals worth $1.12M as of Q2 2026.
XTX Topco sold 33,693 Olema Pharmaceuticals shares in Q2 2026, an estimated $451K.
Olema Pharmaceuticals made up 0.01% of XTX Topco's portfolio in Q2 2026, its #1686 holding.
XTX Topco first reported a position in Olema Pharmaceuticals in Q2 2022 and has held it in 8 quarters since.
XTX Topco's Olema Pharmaceuticals position peaked at $1.84M in Q1 2026.
184 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.